{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:10:20Z","timestamp":1789852220996,"version":"4.0.1"},"reference-count":43,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Retinoid-related molecules (RRMs) are derivatives of retinoic acid and promising antileukemic agents with a mechanism of action different from that of other common chemotherapeutics. Here, we describe a novel chemical series designed against the RRM prototype, CD437. This includes molecules with apoptotic effects in acute promyelocytic leukemia and other myelogenous leukemia cell lines, as well as ST2065, an RRM with antagonistic properties. The most interesting apoptotic agent is ST1926, a compound more powerful than CD437 in vitro and orally active in vivo on severe combined immunodeficiency (SCID) mice that received transplants of NB4 cells. ST1926 has the same mechanism of action of CD437, as indicated by the ability to trans-activate retinoic acid receptor \u03b3, to induce the phosphorylation of p38 and JNK, and to down-regulate the expression of many genes negatively modulated by CD437. ST1926 causes an immediate increase in the cytosolic levels of calcium that are directly related to the apoptotic potential of the RRMs considered. The intracellular calcium elevation is predominantly the result of an inhibition of the mitochondrial calcium uptake. The phenomenon is blocked by the ST2065 antagonist, the intracellular calcium chelator BAPTA (1,2 bis (2-aminophenoxy) ethane-N, N, N\u2032,N\u2032-tetraacetic acid tetrakis (acetoxymethyl ester), and by high concentrations of calcium blockers of the dihydropyridine type, compounds that suppress ST1926-induced apoptosis.<\/jats:p>","DOI":"10.1182\/blood-2003-05-1577","type":"journal-article","created":{"date-parts":[[2003,9,9]],"date-time":"2003-09-09T02:21:21Z","timestamp":1063074081000},"page":"194-207","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":62,"title":["ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis"],"prefix":"10.1182","volume":"103","author":[{"given":"Enrico","family":"Garattini","sequence":"first","affiliation":[{"name":"From the Laboratory of Molecular Biology, Centro Catullo e Daniela Borgomainerio, Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, and Facolta\u0300 di Agraria, Universita\u0300 degli Studi di Milano, Milan, Italy; Facolta\u0300 di Chimica, Dipartimento di Scienze Farmaceutiche, Universita\u0300 di Ferrara, Italy; and Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Pomezia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Parrella","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Biology, Centro Catullo e Daniela Borgomainerio, Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, and Facolta\u0300 di Agraria, Universita\u0300 degli Studi di Milano, Milan, Italy; Facolta\u0300 di Chimica, Dipartimento di Scienze Farmaceutiche, Universita\u0300 di Ferrara, Italy; and Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Pomezia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Diomede","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Biology, Centro Catullo e Daniela Borgomainerio, Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, and Facolta\u0300 di Agraria, Universita\u0300 degli Studi di Milano, Milan, Italy; Facolta\u0300 di Chimica, Dipartimento di Scienze Farmaceutiche, Universita\u0300 di Ferrara, Italy; and Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Pomezia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Gianni'","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Biology, Centro Catullo e Daniela Borgomainerio, Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, and Facolta\u0300 di Agraria, Universita\u0300 degli Studi di Milano, Milan, Italy; Facolta\u0300 di Chimica, Dipartimento di Scienze Farmaceutiche, Universita\u0300 di Ferrara, Italy; and Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Pomezia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesim","family":"Kalac","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Biology, Centro Catullo e Daniela Borgomainerio, Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, and Facolta\u0300 di Agraria, Universita\u0300 degli Studi di Milano, Milan, Italy; Facolta\u0300 di Chimica, Dipartimento di Scienze Farmaceutiche, Universita\u0300 di Ferrara, Italy; and Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Pomezia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Merlini","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Biology, Centro Catullo e Daniela Borgomainerio, Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, and Facolta\u0300 di Agraria, Universita\u0300 degli Studi di Milano, Milan, Italy; Facolta\u0300 di Chimica, Dipartimento di Scienze Farmaceutiche, Universita\u0300 di Ferrara, Italy; and Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Pomezia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Simoni","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Biology, Centro Catullo e Daniela Borgomainerio, Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, and Facolta\u0300 di Agraria, Universita\u0300 degli Studi di Milano, Milan, Italy; Facolta\u0300 di Chimica, Dipartimento di Scienze Farmaceutiche, Universita\u0300 di Ferrara, Italy; and Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Pomezia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Zanier","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Biology, Centro Catullo e Daniela Borgomainerio, Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, and Facolta\u0300 di Agraria, Universita\u0300 degli Studi di Milano, Milan, Italy; Facolta\u0300 di Chimica, Dipartimento di Scienze Farmaceutiche, Universita\u0300 di Ferrara, Italy; and Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Pomezia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Fosca","family":"Ferrara","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Biology, Centro Catullo e Daniela Borgomainerio, Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, and Facolta\u0300 di Agraria, Universita\u0300 degli Studi di Milano, Milan, Italy; Facolta\u0300 di Chimica, Dipartimento di Scienze Farmaceutiche, Universita\u0300 di Ferrara, Italy; and Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Pomezia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Chiarucci","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Biology, Centro Catullo e Daniela Borgomainerio, Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, and Facolta\u0300 di Agraria, Universita\u0300 degli Studi di Milano, Milan, Italy; Facolta\u0300 di Chimica, Dipartimento di Scienze Farmaceutiche, Universita\u0300 di Ferrara, Italy; and Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Pomezia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Carminati","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Biology, Centro Catullo e Daniela Borgomainerio, Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, and Facolta\u0300 di Agraria, Universita\u0300 degli Studi di Milano, Milan, Italy; Facolta\u0300 di Chimica, Dipartimento di Scienze Farmaceutiche, Universita\u0300 di Ferrara, Italy; and Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Pomezia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineko","family":"Terao","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Biology, Centro Catullo e Daniela Borgomainerio, Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, and Facolta\u0300 di Agraria, Universita\u0300 degli Studi di Milano, Milan, Italy; Facolta\u0300 di Chimica, Dipartimento di Scienze Farmaceutiche, Universita\u0300 di Ferrara, Italy; and Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Pomezia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Pisano","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Biology, Centro Catullo e Daniela Borgomainerio, Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, and Facolta\u0300 di Agraria, Universita\u0300 degli Studi di Milano, Milan, Italy; Facolta\u0300 di Chimica, Dipartimento di Scienze Farmaceutiche, Universita\u0300 di Ferrara, Italy; and Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Pomezia, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021221405936000_REF1","unstructured":"Garattini E, Gianni' M, Terao M. Correspondence re: A Kumar et al, cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma. Cancer Res, 61: 7552-7555, 2001. Cancer Res. 2002;62:2192-2193."},{"key":"2020021221405936000_REF2","doi-asserted-by":"crossref","unstructured":"Ponzanelli I, Gianni M, Giavazzi R, et al. Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid. Blood. 2000;95: 2672-2682.","DOI":"10.1182\/blood.V95.8.2672"},{"key":"2020021221405936000_REF3","doi-asserted-by":"crossref","unstructured":"Mologni L, Ponzanelli I, Bresciani F, et al. The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases. Blood. 1999;93: 1045-1061.","DOI":"10.1182\/blood.V93.3.1045"},{"key":"2020021221405936000_REF4","doi-asserted-by":"crossref","unstructured":"Cincinelli R, Dallavalle S, Merlini L, et al. A novel atypical retinoid endowed with proapoptotic and antitumor activity. J Med Chem. 2003;46: 909-912.","DOI":"10.1021\/jm025593y"},{"key":"2020021221405936000_REF5","unstructured":"Lopez-Hernandez FJ, Ortiz MA, Bayon Y, Piedrafita FJ. Z-FA-fmk inhibits effector caspases but not initiator caspases 8 and 10, and demonstrates that novel anticancer retinoid-related molecules induce apoptosis via the intrinsic pathway. Mol Cancer Ther. 2003;2: 255-263."},{"key":"2020021221405936000_REF6","doi-asserted-by":"crossref","unstructured":"Bayon Y, Ortiz MA, Lopez-Hernandez FJ, et al. Inhibition of IkappaB kinase by a new class of retinoid-related anticancer agents that induce apoptosis. Mol Cell Biol. 2003;23: 1061-1074.","DOI":"10.1128\/MCB.23.3.1061-1074.2003"},{"key":"2020021221405936000_REF7","doi-asserted-by":"crossref","unstructured":"Zhang Y, Dawson MI, Mohammad R, et al. Induction of apoptosis of human B-CLL and ALL cells by a novel retinoid and its nonretinoidal analog. Blood. 2002;100: 2917-2925.","DOI":"10.1182\/blood.V100.8.2917"},{"key":"2020021221405936000_REF8","doi-asserted-by":"crossref","unstructured":"Holmes WF, Soprano DR, Soprano KJ. Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line. J Biol Chem. 2002;277: 45408-45419.","DOI":"10.1074\/jbc.M204600200"},{"key":"2020021221405936000_REF9","unstructured":"Sun SY, Yue P, Chen X, Hong WK, Lotan R. The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells. Cancer Res. 2002;62: 2430-2436."},{"key":"2020021221405936000_REF10","doi-asserted-by":"crossref","unstructured":"Belzacq AS, El Hamel C, Vieira HL, et al. Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437. Oncogene. 2001;20: 7579-7587.","DOI":"10.1038\/sj.onc.1204953"},{"key":"2020021221405936000_REF11","unstructured":"Wan X, Duncan MD, Nass P, Harmon JW. Synthetic retinoid CD437 induces apoptosis of esophageal squamous HET-1A cells through the caspase-3-dependent pathway. Anticancer Res. 2001;21: 2657-2663."},{"key":"2020021221405936000_REF12","doi-asserted-by":"crossref","unstructured":"Zhao X, Demary K, Wong L, et al. Retinoic acid receptor-independent mechanism of apoptosis of melanoma cells by the retinoid CD437 (AHPN). Cell Death Differ. 2001;8: 878-886.","DOI":"10.1038\/sj.cdd.4400894"},{"key":"2020021221405936000_REF13","doi-asserted-by":"crossref","unstructured":"Zang Y, Beard RL, Chandraratna RA, Kang JX. Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells. Cell Death Differ. 2001;8: 477-485.","DOI":"10.1038\/sj.cdd.4400843"},{"key":"2020021221405936000_REF14","doi-asserted-by":"crossref","unstructured":"Gianni M, Zanotta S, Terao M, Garattini S, Garattini E. Effects of synthetic retinoids and retinoic acid isomers on the expression of alkaline phosphatase in F9 teratocarcinoma cells. Biochem Biophys Res Commun. 1993;196: 252-259.","DOI":"10.1006\/bbrc.1993.2242"},{"key":"2020021221405936000_REF15","doi-asserted-by":"crossref","unstructured":"Schadendorf D, Worm M, Jurgovsky K, Dippel E, Reichert U, Czarnetzki BM. Effects of various synthetic retinoids on proliferation and immunophenotype of human melanoma cells in vitro. Recent Results Cancer Res. 1995;139: 183-193.","DOI":"10.1007\/978-3-642-78771-3_13"},{"key":"2020021221405936000_REF16","doi-asserted-by":"crossref","unstructured":"Falanga A, Consonni R, Marchetti M, et al. Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells. Blood. 1998;92: 143-151.","DOI":"10.1182\/blood.V92.1.143.413k18_143_151"},{"key":"2020021221405936000_REF17","doi-asserted-by":"crossref","unstructured":"Hsu CA, Rishi AK, Su-Li X, et al. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. Blood. 1997;89: 4470-4479.","DOI":"10.1182\/blood.V89.12.4470"},{"key":"2020021221405936000_REF18","doi-asserted-by":"crossref","unstructured":"Holmes WF, Soprano DR, Soprano KJ. Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR. J Cell Biochem. 2003;89: 262-278.","DOI":"10.1002\/jcb.10505"},{"key":"2020021221405936000_REF19","unstructured":"Marchetti P, Zamzami N, Joseph B, et al. The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus. Cancer Res. 1999;59: 6257-6266."},{"key":"2020021221405936000_REF20","doi-asserted-by":"crossref","unstructured":"Holmes WF, Soprano DR, Soprano KJ. Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line. J Biol Chem. 2002;277: 45408-45419.","DOI":"10.1074\/jbc.M204600200"},{"key":"2020021221405936000_REF21","doi-asserted-by":"crossref","unstructured":"Costantini P, Jacotot E, Decaudin D, Kroemer G. Mitochondrion as a novel target of anticancer chemotherapy. J Natl Cancer Inst. 2000;92: 1042-1053.","DOI":"10.1093\/jnci\/92.13.1042"},{"key":"2020021221405936000_REF22","doi-asserted-by":"crossref","unstructured":"Zhang Y, Huang Y, Rishi AK, et al. Activation of the p38 and JNK\/SAPK mitogen-activated protein kinase pathways during apoptosis is mediated by a novel retinoid. Exp Cell Res. 1999;247: 233-240.","DOI":"10.1006\/excr.1998.4350"},{"key":"2020021221405936000_REF23","doi-asserted-by":"crossref","unstructured":"Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood. 1991;77: 1080-1086.","DOI":"10.1182\/blood.V77.5.1080.1080"},{"key":"2020021221405936000_REF24","doi-asserted-by":"crossref","unstructured":"Pisano C, Kollar P, Gianni M, et al. Bis-indols: a novel class of molecules enhancing the cytodifferentiating properties of retinoids in myeloid leukemia cells. Blood. 2002;100: 3719-3730.","DOI":"10.1182\/blood-2002-03-0720"},{"key":"2020021221405936000_REF25","doi-asserted-by":"crossref","unstructured":"Gianni M, Bauer A, Garattini E, Chambon P, Rochette-Egly C. Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RAR gamma degradation and transactivation. EMBO J. 2002;21: 3760-3769.","DOI":"10.1093\/emboj\/cdf374"},{"key":"2020021221405936000_REF26","doi-asserted-by":"crossref","unstructured":"Gianni M, Kopf E, Bastien J, et al. Down-regulation of the phosphatidylinositol 3-kinase\/Akt pathway is involved in retinoic acid-induced phosphorylation, degradation, and transcriptional activity of retinoic acid receptor gamma 2. J Biol Chem. 2002;277: 24859-24862.","DOI":"10.1074\/jbc.C200230200"},{"key":"2020021221405936000_REF27","doi-asserted-by":"crossref","unstructured":"Gianni' M, Terao M, Zanotta S. Barbui T, Rambaldi A, Garattini E. Retinoic acid and granulocyte-colony stimulating factor sinergistically induce leukocyte alkaline phosphatase in acute promyelocytic lekemia cells. Blood. 1994;83: 1909-1921.","DOI":"10.1182\/blood.V83.7.1909.1909"},{"key":"2020021221405936000_REF28","doi-asserted-by":"crossref","unstructured":"Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260: 3440-3450.","DOI":"10.1016\/S0021-9258(19)83641-4"},{"key":"2020021221405936000_REF29","doi-asserted-by":"crossref","unstructured":"Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2000;1: 11-21.","DOI":"10.1038\/35036035"},{"key":"2020021221405936000_REF30","doi-asserted-by":"crossref","unstructured":"Hajnoczky G, Csordas G, Madesh M, Pacher P. Control of apoptosis by IP(3) and ryanodine receptor driven calcium signals. Cell Calcium. 2000;28: 349-363.","DOI":"10.1054\/ceca.2000.0169"},{"key":"2020021221405936000_REF31","doi-asserted-by":"crossref","unstructured":"Craig PJ, Beattie RE, Folly EA, et al. Distribution of the voltage-dependent calcium channel alpha1G subunit mRNA and protein throughout the mature rat brain. Eur J Neurosci. 1999;11: 2949-2964.","DOI":"10.1046\/j.1460-9568.1999.00711.x"},{"key":"2020021221405936000_REF32","doi-asserted-by":"crossref","unstructured":"Talajic M, Nattel S. Frequency-dependent effects of calcium antagonists on atrioventricular conduction and refractoriness: demonstration and characterization in anesthetized dogs. Circulation. 1986;74: 1156-1167.","DOI":"10.1161\/01.CIR.74.5.1156"},{"key":"2020021221405936000_REF33","doi-asserted-by":"crossref","unstructured":"Ho MK, Wong YH. G(z) signaling: emerging divergence from G(i) signaling. Oncogene. 2001; 20: 1615-1625.","DOI":"10.1038\/sj.onc.1204190"},{"key":"2020021221405936000_REF34","doi-asserted-by":"crossref","unstructured":"Moore GA, McConkey DJ, Kass GE, O'Brien PJ, Orrenius S. 2,5-Di(tert-butyl)-1,4-benzohydroquinonea novel inhibitor of liver microsomal Ca2+ sequestration. FEBS Lett. 1987;224: 331-336.","DOI":"10.1016\/0014-5793(87)80479-9"},{"key":"2020021221405936000_REF35","doi-asserted-by":"crossref","unstructured":"Treiman M, Caspersen C, Christensen SB. A tool coming of age: thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca2+-ATPases. Trends Pharmacol Sci. 1998;19: 131-135.","DOI":"10.1016\/S0165-6147(98)01184-5"},{"key":"2020021221405936000_REF36","doi-asserted-by":"crossref","unstructured":"Launay S, Gianni M, Diomede L, Machesky LM, Enouf J, Papp B. Enhancement of ATRA-induced cell differentiation by inhibition of calcium accumulation into the endoplasmic reticulum: cross-talk between RAR alpha and calcium-dependent signaling. Blood. 2003;101: 3220-3228.","DOI":"10.1182\/blood-2002-09-2730"},{"key":"2020021221405936000_REF37","doi-asserted-by":"crossref","unstructured":"Gunter TE, Pfeiffer DR. Mechanisms by which mitochondria transport calcium. Am J Physiol. 1990;258: C755-C786.","DOI":"10.1152\/ajpcell.1990.258.5.C755"},{"key":"2020021221405936000_REF38","doi-asserted-by":"crossref","unstructured":"Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J. 1999;341: 233-249.","DOI":"10.1042\/bj3410233"},{"key":"2020021221405936000_REF39","doi-asserted-by":"crossref","unstructured":"Crompton M, Kunzi M, Carafoli E. The calcium-induced and sodium-induced effluxes of calcium from heart mitochondria: evidence for a sodium-calcium carrier. Eur J Biochem. 1977;79: 549-558.","DOI":"10.1111\/j.1432-1033.1977.tb11839.x"},{"key":"2020021221405936000_REF40","doi-asserted-by":"crossref","unstructured":"Szewczyk A, Wojtczak L. Mitochondria as a pharmacological target. Pharmacol Rev. 2002;54: 101-127.","DOI":"10.1124\/pr.54.1.101"},{"key":"2020021221405936000_REF41","doi-asserted-by":"crossref","unstructured":"Petronilli V, Penzo D, Scorrano L, Bernardi P, Di Lisa F. The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ. J Biol Chem. 2001;276: 12030-12034.","DOI":"10.1074\/jbc.M010604200"},{"key":"2020021221405936000_REF42","doi-asserted-by":"crossref","unstructured":"Korshunov SS, Skulachev VP, Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 1997;416: 15-18.","DOI":"10.1016\/S0014-5793(97)01159-9"},{"key":"2020021221405936000_REF43","doi-asserted-by":"crossref","unstructured":"Taylor CW. Controlling calcium entry. Cell. 2002; 111: 767-769.","DOI":"10.1016\/S0092-8674(02)01197-2"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/1\/194\/1694121\/zh800104000194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/1\/194\/1694121\/zh800104000194.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T17:11:36Z","timestamp":1623345096000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/103\/1\/194\/17605\/ST1926-a-novel-and-orally-active-retinoidrelated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-05-1577","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,1]]}}}